Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer

Simav Gildiz1, Tamara Minko2,3

  • 1Department of Pharmaceutics, Rutgers, the State University of New Jersey, Piscataway, NJ, USA.

Pharmaceutical Research
|November 14, 2022
PubMed

Insights

Messenger RNA (mRNA) vaccines show promise for treating cancer, but none are FDA-approved yet. This review covers mRNA and nanotechnology approaches for ovarian cancer treatment.

Area of Science:

  • Oncology
  • Vaccinology
  • Biotechnology

Background:

  • Anticancer vaccines are a promising therapeutic strategy.
  • Nucleic acid-based vaccines have advanced significantly for other diseases.
  • Current research explores mRNA vaccines for various cancers.

Purpose of the Study:

  • To review major treatment approaches for ovarian cancer.
  • To analyze the role of mRNA-based vaccines in ovarian cancer therapy.
  • To summarize nanotechnology-based delivery systems for cancer vaccines.

Main Methods:

  • Literature review of current research and clinical trials.
  • Analysis of mRNA vaccine technology for cancer treatment.
  • Evaluation of nanotechnology applications in vaccine delivery.

Main Results:

  • While promising, no mRNA cancer vaccines are currently FDA-approved.
  • Several clinical trials are investigating mRNA vaccines for different cancers.
  • Nanotechnology offers potential for improved vaccine delivery.

Conclusions:

  • mRNA vaccines represent a prospective direction for cancer research and development.
  • Nanotechnology-based approaches are crucial for effective mRNA vaccine delivery.
  • Further research is needed to advance ovarian cancer vaccine therapies.

Related Concept Videos

Nucleic acids02:43

Nucleic acids

Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
165.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
483
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
176